Plasma homocysteine, methylenetetrahydrofolate reductase mutation and carotid damage in elderly healthy women
- 1 July 2001
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 157 (1) , 175-180
- https://doi.org/10.1016/s0021-9150(00)00696-1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- A methylenetetrahydrofolate reductase gene polymorphism in ischaemic stroke and in carotid artery stenosisEuropean Journal of Clinical Investigation, 1998
- C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populationsAtherosclerosis, 1998
- Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study.Journal of Clinical Investigation, 1996
- Distribution in Healthy and Coronary Populations of the Methylenetetrahydrofolate Reductase (MTHFR) C 677 T MutationArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- The effect of reduced glomerular filtration rate on plasma total homocysteine concentrationScandinavian Journal of Clinical and Laboratory Investigation, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Arterial wall oxygenation, oxyradicals, and atherosclerosisAtherosclerosis, 1991
- Estimates of heritability of plasma homocyst(e)ine levels in aging adult male twinsClinical Genetics, 1991
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991
- Mechanisms of Thrombogenesis and Accelerated Atherogenesis in HomocysteinaemiaPathophysiology of Haemostasis and Thrombosis, 1989